While ZC3H7B::BCOR fusions have been reported in a rare subset of OFMT, it remains currently unclear whether ZC3H7B::BCOR fusion-associated soft tissue neoplasms belong to the spectrum of OFMT and BCOR-rearranged sarcomas (as a molecular subtype), represent a distinctive category of fusion-driven fibromyxoid sarcomas or form a heterogeneous category comprising both. This evidence concerns the gene BCOR and ossifying fibromyxoid tumor.